Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Top 5 Mid Cap Mutual Funds in 1 Year: Mid cap mutual funds have at least 65 per cent of their investment in mid cap stocks. They have gone through many fluctuations in the last 1 year because of the ...

As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and collaborators ...

Small-cap penny stock Murae Organisor hit 5% upper circuit limit as the board is expected to declare a stock split. The company has revealed that it will deliberate on a significant corporate ...

Sunshine Biopharma's K1.1 mRNA-LNP reduced human HCC tumor growth in mice with good tolerability under repeated dosing. The company's 2024 revenue rose 45% year over year to $34.9 million.

Looking for your next binge-worthy watch? Prime Video has a stellar lineup of must-watch shows that cater to every kind of viewer. Barry Jenkins's stunning adaptation of Colson Whitehead’s ...

Metroid Prime 5 could be a real showcase of what the Switch 2 is uniquely capable of. There’s some genuinely fascinating rumors that point to a bolder and more ambitious Nintendo, as we may see ...

As of April 1, 2025, the average one-year price target for Xencor is $30.86/share. The forecasts range from a low of $22.22 to a high of $42.00. The average price target represents an increase of ...